This Article Full Text Free Full Text (PDF) Free Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Moors, M. A. Articles by Mizel, S. B. Search for Related Content PubMed PubMed Citation Articles by Moors, M. A. Articles by Mizel, S. B.

(Journal of Leukocyte Biology. 2000;68:131-136.)
© 2000 by Society for Leukocyte Biology

Proteasome-mediated regulation of interleukin-1ß turnover and export in human monocytes

Department of Microbiology and Immunology, Wake Forest University Medical Center, Winston-Salem, North Carolina

Correspondence: Steven Mizel, Dept. of Microbiology and Immunology, Wake Forest University Medical Center, Winston-Salem, NC 27157. E-mail: smizel{at}wfubmc.edu

Interleukin-1ß is a secreted protein that accumulates in the cytosol as an inactive precursor (pIL-1ß) before processing and release of biologically active protein. To understand the impact of this property on IL-1ß production, we examined the intracellular stability of pIL-1ß in lipopolysaccharide (LPS)-stimulated human monocytes. Precursor IL-1ß was degraded with a relatively short half-life of 2.5 h in the promonocytic cell line, THP-1, and in primary monocytes. MG132 (carbobenzoxyl-leucinyl-leucinyl-leucinal) stabilized pIL-1ß levels in THP-1 cells, suggesting that degradation was proteasome-mediated, but this inhibitor was toxic for primary monocytes, causing release of pIL-1ß as well as the cytoplasmic enzyme, lactate dehydrogenase (LDH) into supernatants. In contrast, clasto-lactacystin ß-lactone, a specific inhibitor of the proteasome, caused a dose-dependent stabilization of intracellular pIL-1ß, and this led to a corresponding increase in mIL-1ß and pIL-1ß but not LDH release into culture supernatants. Therefore, by regulating intracellular levels of precursor IL-1ß, the proteasome plays an important and previously unrecognized role in controlling the amount of biologically active IL-1ß that is exported by activated monocytes.

Key Words: THP-1 • MG132 • lactacystin • precursor interleukin-1ß • degradation

This article has been cited by other articles:

				K. H. Kurji, J. Z. Cui, T. Lin, D. Harriman, S. S. Prasad, L. Kojic, and J. A. Matsubara Microarray Analysis Identifies Changes in Inflammatory Gene Expression in Response to Amyloid-{beta} Stimulation of Cultured Human Retinal Pigment Epithelial Cells Invest. Ophthalmol. Vis. Sci., February 1, 2010; 51(2): 1151 - 1163. [Abstract] [Full Text] [PDF]

				J. Hernandez-Rodriguez, M. Segarra, C. Vilardell, M. Sanchez, A. Garcia-Martinez, M. J. Esteban, C. Queralt, J. M. Grau, A. Urbano-Marquez, A. Palacin, et al. Tissue production of pro-inflammatory cytokines (IL-1{beta}, TNF{alpha} and IL-6) correlates with the intensity of the systemic inflammatory response and with corticosteroid requirements in giant-cell arteritis Rheumatology, March 1, 2004; 43(3): 294 - 301. [Abstract] [Full Text] [PDF]

				N. Qureshi, P.-Y. Perera, J. Shen, G. Zhang, A. Lenschat, G. Splitter, D. C. Morrison, and S. N. Vogel The Proteasome as a Lipopolysaccharide-Binding Protein in Macrophages: Differential Effects of Proteasome Inhibition on Lipopolysaccharide-Induced Signaling Events J. Immunol., August 1, 2003; 171(3): 1515 - 1525. [Abstract] [Full Text] [PDF]